Pluri Inc. (TLV:PLUR)
1,080.00
-76.00 (-6.57%)
Nov 6, 2025, 5:24 PM IDT
Pluri Revenue
In the fiscal year ending June 30, 2025, Pluri had annual revenue of $1.34M USD with 309.82% growth. Pluri had revenue of $398.00K in the quarter ending June 30, 2025, with 314.58% growth.
Revenue
$1.34M
Revenue Growth
+309.82%
P/S Ratio
19.46
Revenue / Employee
$9.41K
Employees
142
Market Cap
87.59M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.34M | 1.01M | 309.82% |
| Jun 30, 2024 | 326.00K | 39.00K | 13.59% |
| Jun 30, 2023 | 287.00K | 53.00K | 22.65% |
| Jun 30, 2022 | 234.00K | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.84B |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 927.57M |
| Kamada | 571.15M |
| SofWave Medical | 255.13M |
| InterCure | 243.12M |
| BrainsWay | 155.27M |